These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31478423)

  • 1. Successful perinatal management of a dichorionic diamniotic twin pregnancy in an anaemic kidney transplant patient treated with Darbepoetin alfa: a case report.
    Tamaki S; Shinoda K; Matsumoto T; Morita S; Asanuma H; Yoshida T; Oya M
    J Obstet Gynaecol; 2020 Apr; 40(3):427-429. PubMed ID: 31478423
    [No Abstract]   [Full Text] [Related]  

  • 2. Darbepoetin alfa for treatment of anaemia in a case of chronic renal failure during pregnancy--case report.
    Ghosh A; Ayers KJ
    Clin Exp Obstet Gynecol; 2007; 34(3):193-4. PubMed ID: 17937101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo weekly and biweekly darbepoetin alfa dosing in pediatric patients with chronic kidney disease.
    Warady BA; Barcia J; Benador N; Jankauskiene A; Olson K; Podracka L; Shavkin A; Srivaths P; Wong CJ; Petersen J
    Pediatr Nephrol; 2018 Jan; 33(1):125-137. PubMed ID: 28815341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of pain and efficacy of darbepoetin alfa and epoetin Beta pegol treatment in patients receiving peritoneal dialysis.
    Otsuka T; Sakai Y; Yui S; Sukegawa M; Suzuki A; Mugishima K; Sumi Y; Otsuka Y; Tsuruoka S
    J Nippon Med Sch; 2015; 82(1):21-6. PubMed ID: 25797871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-monthly pegylated epoetin Beta versus darbepoetin alfa every two weeks in renal transplant recipients: a randomized trial.
    Campistol JM; Carreño A; Morales JM; Pallardó L; Franco A; Navarro D; Grinyó JM; Montenegro J; Sánchez Fructuoso AI; Romero R; Guirado L; Arias M;
    Transplantation; 2013 Jan; 95(2):e6-e10. PubMed ID: 23325012
    [No Abstract]   [Full Text] [Related]  

  • 6. Darbepoetin alfa treatment for post-renal transplantation anemia during pregnancy.
    Goshorn J; Youell TD
    Am J Kidney Dis; 2005 Nov; 46(5):e81-6. PubMed ID: 16253714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan.
    Tanaka T; Nangaku M; Imai E; Tsubakihara Y; Kamai M; Wada M; Asada S; Akizawa T
    Clin Exp Nephrol; 2019 Feb; 23(2):231-243. PubMed ID: 30182223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose efficiency of erythropoiesis-stimulating agents for the treatment of patients with chemotherapy-induced anemia: a systematic review.
    Forbes CA; Worthy G; Harker J; Kleijnen J; Kutikova L; Zelek L; Van Belle S
    Clin Ther; 2014 Apr; 36(4):594-610. PubMed ID: 24656152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial.
    Sinha SD; Bandi VK; Bheemareddy BR; Thakur P; Chary S; Mehta K; Pinnamareddy VR; Pandey R; Sreepada S; Durugkar S
    BMC Nephrol; 2019 Mar; 20(1):90. PubMed ID: 30866856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twin pregnancy after kidney transplantation: what's on? A case report and review of literature.
    Gizzo S; Noventa M; Saccardi C; Paccagnella G; Patrelli TS; Cosmi E; D'Antona D
    J Matern Fetal Neonatal Med; 2014 Nov; 27(17):1816-9. PubMed ID: 24397798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Darbepoetin for the anaemia of chronic kidney disease.
    Palmer SC; Saglimbene V; Craig JC; Navaneethan SD; Strippoli GF
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD009297. PubMed ID: 24683046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, dose-finding study of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies.
    Hedenus M; Hansen S; Taylor K; Arthur C; Emmerich B; Dewey C; Watson D; Rossi G; Osterborg A;
    Br J Haematol; 2002 Oct; 119(1):79-86. PubMed ID: 12358906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a simple dosage scheme to convert from shorter-acting erythropoiesis-stimulating agent to continuous erythropoietin receptor activator in kidney transplantation patients.
    Sánchez-Escuredo A; Batista F; Cases A; Torregrosa JV
    Transplant Proc; 2015; 47(1):73-5. PubMed ID: 25645774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Darbepoetin-alfa in renal-transplant patients: an observational monocentric study.
    Ribes D; Kamar N; Guitard J; Esposito L; Rostaing L
    Clin Nephrol; 2008 Feb; 69(2):102-6. PubMed ID: 18218303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anemia treatment with darbepoetin alpha in pregnant female with chronic renal failure: report of two cases.
    Sobiło-Jarek L; Popowska-Drojecka J; Muszytowski M; Wanic-Kossowska M; Kobelski M; Czekalski S
    Adv Med Sci; 2006; 51():309-11. PubMed ID: 17357331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoiesis-stimulating agents in sickle cell anaemia.
    Han J; Zhou J; Kondragunta V; Zhang X; Molokie RE; Gowhari M; Hassan J; Jain S; Calip GS; Gordeuk VR; Saraf SL
    Br J Haematol; 2018 Aug; 182(4):602-605. PubMed ID: 28748552
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-Term Efficacy and Safety of Molidustat for Anemia in Chronic Kidney Disease: DIALOGUE Extension Studies.
    Akizawa T; Macdougall IC; Berns JS; Bernhardt T; Staedtler G; Taguchi M; Iekushi K; Krueger T
    Am J Nephrol; 2019; 49(4):271-280. PubMed ID: 30852574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of weekly epoetin alfa versus biweekly darbepoetin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomised trial.
    Reed SD; Radeva JI; Daniel DB; Mody SH; Forlenza JB; McKenzie RS; Schulman KA
    Pharmacoeconomics; 2006; 24(5):479-94. PubMed ID: 16706573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in patients with chronic kidney disease not on dialysis receiving extended dosing regimens of darbepoetin alfa: long-term results of the EXTEND observational cohort study.
    Galle JC; Addison J; Suranyi MG; Claes K; Di Giulio S; Guerin A; Herlitz H; Kiss I; Farouk M; Manamley N; Wirnsberger G; Winearls C
    Nephrol Dial Transplant; 2016 Dec; 31(12):2073-2085. PubMed ID: 27190334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized comparison of once weekly epoetin alfa to extended schedule epoetin or darbepoetin in chemotherapy-associated anemia.
    Steensma DP; Dakhil SR; Novotny PJ; Sloan JA; Johnson DB; Anderson DM; Mattar BI; Moore DF; Nikcevich D; Loprinzi CL
    Am J Hematol; 2015 Oct; 90(10):877-81. PubMed ID: 26149465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.